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Transition towards continuous production has gained serious attention from the pharmaceutical 
industry as well as its regulatory authorities, mainly because of its economic, product related and 
environmental benefits. Clearly, such manufacturing systems require a combination of advanced 
process measurement tools, a thorough understanding of the process dynamics and an effective 
yet robust control strategy allowing real-time release. Therefore, continuous manufacturing in the 
pharmaceutical industry demands a well-advised plan of action.  
In this study, the focus is on an innovative continuous from-powder-to-tablet production line used 
for secondary manufacturing of pharmaceutical tablets, ConsiGmaTM. Recent advances in both 
process analysers as well as the ongoing development of validated mechanistic models for the 
granulation and drying sub-processes, have paved the way for closed-loop control of the 
considered continuous wet granulation and drying line. Typically, this line comes with a regulatory 
control layer capable of controlling nine univariate critical process parameters (e.g. drying 
temperature, screw speed and air flow rate). However, critical quality attributes (e.g. granule size 
distribution, granule shape, density and residual moisture content), i.e. the variables directly 
related to the quality of the product itself, are not measured nor controlled in real-time, hence 
nullifying most of the advantages of continuous processing. Therefore, the purpose of current 
research is to extend the regulatory control layer of the system by adding additional control loops 
which allow for direct control of product quality related properties.  
A first step towards this objective was the identification of all control relevant product variables 
and the selection of a suitable operating point in the accompanying design space. Subsequently, 
the dynamic behaviour of the system around this operating point needs a thorough investigation 
in order to develop suitable multiple-input multiple-output (MIMO) control strategies (e.g. 
decentralised control and decoupled control) using computer-aided design tools.  
The ultimate goal of this ongoing study is the development of a system-wide supervisory control 
layer capable of controlling the different sub-processes as one integrated system. Eventually, this 
could unlock the full potential of the considered continuous manufacturing line as well as 
continuous production in the pharmaceutical industry as a whole. 
